Related references
Note: Only part of the references are listed.Inhibition of SIRT2 suppresses hepatic fibrosis
Maribel Arteaga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
FAK Kinase Activity Is Required for the Progression of c-MET/β-Catenin-Driven Hepataocellular Carcinoma
Na Shang et al.
GENE EXPRESSION (2016)
FAK Is Required for c-Met/beta-Catenin-Driven Hepatocarcinogenesis
Na Shang et al.
HEPATOLOGY (2015)
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Rajagopal N. Aravalli et al.
ARCHIVES OF TOXICOLOGY (2013)
Caspase Functions in Cell Death and Disease
David R. McIlwain et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Cellular Mechanisms Controlling Caspase Activation and Function
Amanda B. Parrish et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Paracrine control of tissue regeneration and cell proliferation by Caspase-3
K. Boland et al.
CELL DEATH & DISEASE (2013)
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches
Ekihiro Seki et al.
GASTROENTEROLOGY (2012)
Caspase Substrates and Cellular Remodeling
Emily D. Crawford et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
PUMA-Mediated Apoptosis Drives Chemical Hepatocarcinogenesis in Mice
Wei Qiu et al.
HEPATOLOGY (2011)
Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection
Hua Huang et al.
CANCER SCIENCE (2010)
DBM1285 Suppresses Tumor Necrosis Factor α Production by Blocking p38 Mitogen-Activated Protein Kinase/Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Signaling Pathway
Jong Soon Kang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
NF-κB as a Critical Link Between Inflammation and Cancer
Michael Karin
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
Toshiharu Sakurai et al.
CANCER CELL (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells
Wolfgang Breitwieser et al.
GENES & DEVELOPMENT (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Toshiharu Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanisms of liver injury.: I.: TNF-α-induced liver injury:: role of IKK, JNK, and ROS pathways
RF Schwabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Caspase activation, inhibition, and reactivation: A mechanistic view
YG Shi
PROTEIN SCIENCE (2004)
Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma
K Iyoda et al.
CANCER (2003)
c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration
RF Schwabe et al.
HEPATOLOGY (2003)
Many cuts to ruin: a comprehensive update of caspase substrates
U Fischer et al.
CELL DEATH AND DIFFERENTIATION (2003)
Share Paper
